- Most markets closed for holidays
- US sanctions European officials
- Meta under Italian scrutiny
- Sanofi purchases US vaccine developer
- Most markets closed for holidays
- US sanctions European officials
- Meta under Italian scrutiny
- Sanofi purchases US vaccine developer
Volatility and trading on European exchanges are noticeably reduced due to the closure of many of them during the Christmas holidays. Trading will not take place on exchanges in Germany, Italy, Switzerland, Poland, the Czech Republic, Scandinavia, and the Baltic countries. Trading hours are shortened to 12:30 in the UK, 14:00 in Spain, and 14:05 in France. Among contracts, FRA40 is recording gains, rising by 0.3% today.
Despite the lack of significant readings on the continent and reduced investor activity, there will still be price-forming factors that may be discounted after the holiday period ends.
The USA has announced visa sanctions on five European commissioners involved in legislation related to digital services in the EU. Despite multiple indications of monopolistic practices and illegal data processing by American tech companies, President Donald Trump's administration maintains that the penalties are political and opinion-forming. This event is a radical escalation of tensions between Europe and the USA, which will undoubtedly be reflected in market valuations over time.
At the same time, the dispute between the Italian regulator (AGCM) and Meta is intensifying. Italy has decided to order the suspension of certain contractual provisions with WhatsApp, which the regulator claims abuse the market leader position and harm customers.
Macroeconomic Data:
- In the USA, data on unemployment benefit claims will be published, with a reading significantly divergent from market expectations potentially affecting, among other things, the strength of the Euro against the Dollar. Approximately 224,000 new claims are expected.
FRA40 (D1)
Source: xStation5
The price remains in a long-term upward channel, but momentum is noticeably declining. Buyers have once again failed to overcome local peaks at the level of 8320, and the price is increasingly oscillating in the lower boundary of the upward trend channel. For the supply side, the first target is a breakout below the channel towards FIBO 23.6, which could provide room for further declines.
Company News:
- Sanofi (SAN.FR) - The French pharmaceutical giant announced the acquisition of California-based company Dynavax for $2.2 billion in cash. At the same time, the company is under pressure from regulatory delays on the FDA side, which is postponing the decision regarding one of the new drugs for multiple sclerosis.
- Supermarket Income REIT (SUPR.UK) - Purchased three supermarkets in the UK for 97.6 million pounds.
US OPEN: Holiday season extinguish volatility despite political risks
BREAKING: BoE cuts interest rates. GBPUSD rebounds
DE40: Many informations, few movements
⏫Oil rallies 2% on Supply Uncertainty
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
